REGN vs SMTC · P/E 14, rev $4.29B vs rev $1.05B
Regeneron Pharmaceuticals Inc (REGN) versus Semtech Corporation (SMTC) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Semtech Corporation (SMTC) is a semiconductors company listed on US.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SMTC revenue for 2026-01-25 was $1.05B. Net income was -$40.4M. Revenue was up 15.5% from 2025-01-26 to 2026-01-25. SMTC currently screens at market cap $14.07B.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SMTC currently screens at market cap $14.07B.
Not investment advice. Open the REGN and SMTC stock pages for the full models.
Not investment advice.